COVID-19 and Anti-CD14 Treatment Trial

Clinical trial NCT04391309 · TERMINATED

Trial details

NCT number: NCT04391309
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Coronavirus Disease 2019 (COVID-19)Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Start date: 2021-04-12
Primary completion: 2022-02-04
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.